HCA Healthcare (NYSE:HCA) Given New $450.00 Price Target at Robert W. Baird
HCA Healthcare (NYSE:HCA – Free Report) had its target price raised by Robert W. Baird from $423.00 to $450.00 in a report issued on Thursday,MarketScreener reports. The brokerage currently has a neutral rating on the stock. Several other research firms have also commented on HCA. Weiss Ratings reiterated a “buy (b)” rating on shares of […]
12 Dec 15:49 · The Markets Daily